The 2023 chemotherapy shortage led to a 60% drop in cisplatin use for head and neck cancer, with costly substitutes ...

DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, ...

A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...

During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared ...

An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and ...

A prospective, longitudinal study sought to determine the effects of nutrition status, daily habits, and sleep pattern on length of stay in patients with ovarian cancer undergoing chemotherapy.

Researchers from the RMIT University in Australia and Indian institutions unveiled a gold-based cancer drug with promising ...

Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...

Similarly, we observed that pretreatment of EA sensitizes the cisplatin-resistant C13 ovarian cancer cell line to cisplatin treatment (Figure 6C). In summary, our data showed that EA treatment reduces ...